FI20125888A - Anisomelihapon farmaseuttiset koostumukset ja niiden käyttö - Google Patents

Anisomelihapon farmaseuttiset koostumukset ja niiden käyttö

Info

Publication number
FI20125888A
FI20125888A FI20125888A FI20125888A FI20125888A FI 20125888 A FI20125888 A FI 20125888A FI 20125888 A FI20125888 A FI 20125888A FI 20125888 A FI20125888 A FI 20125888A FI 20125888 A FI20125888 A FI 20125888A
Authority
FI
Finland
Prior art keywords
pharmaceutical compositions
anisomelic acid
anisomelic
acid
pharmaceutical
Prior art date
Application number
FI20125888A
Other languages
English (en)
Swedish (sv)
Other versions
FI126047B (fi
Inventor
John Eriksson
Paul Preethy
Emilia Peuhu
M A Akbarsha
Original Assignee
John Eriksson
Paul Preethy
Emilia Peuhu
M A Akbarsha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FI20125888A priority Critical patent/FI126047B/fi
Application filed by John Eriksson, Paul Preethy, Emilia Peuhu, M A Akbarsha filed Critical John Eriksson
Priority to JP2015529085A priority patent/JP2015530381A/ja
Priority to PCT/FI2013/050828 priority patent/WO2014033366A1/en
Priority to US14/423,711 priority patent/US9345687B2/en
Priority to DK13792713.3T priority patent/DK2895162T3/en
Priority to EP13792713.3A priority patent/EP2895162B1/en
Priority to CN201380056583.3A priority patent/CN104869991B/zh
Priority to CA2922642A priority patent/CA2922642C/en
Publication of FI20125888A publication Critical patent/FI20125888A/fi
Priority to US14/827,343 priority patent/US9623002B2/en
Application granted granted Critical
Publication of FI126047B publication Critical patent/FI126047B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
FI20125888A 2012-08-28 2012-08-28 Anisomelihapon farmaseuttiset koostumukset ja niiden käyttö FI126047B (fi)

Priority Applications (9)

Application Number Priority Date Filing Date Title
FI20125888A FI126047B (fi) 2012-08-28 2012-08-28 Anisomelihapon farmaseuttiset koostumukset ja niiden käyttö
PCT/FI2013/050828 WO2014033366A1 (en) 2012-08-28 2013-08-28 Pharmaceutical compositions of anisomelic acid and the use thereof
US14/423,711 US9345687B2 (en) 2012-08-28 2013-08-28 Pharmaceutical compositions of anisomelic acid and the use thereof
DK13792713.3T DK2895162T3 (en) 2012-08-28 2013-08-28 PHARMACEUTICAL COMPOSITIONS OF ANISOMELY ACID AND ITS APPLICATION
JP2015529085A JP2015530381A (ja) 2012-08-28 2013-08-28 アニソメル酸の医薬組成物およびその使用
EP13792713.3A EP2895162B1 (en) 2012-08-28 2013-08-28 Pharmaceutical compositions of anisomelic acid and the use thereof
CN201380056583.3A CN104869991B (zh) 2012-08-28 2013-08-28 防风草酸的药物组合物及其应用
CA2922642A CA2922642C (en) 2012-08-28 2013-08-28 Pharmaceutical compositions of anisomelic acid and the use thereof
US14/827,343 US9623002B2 (en) 2012-08-28 2015-08-17 Pharmaceutical compositions of Anisomelic acid and the use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20125888A FI126047B (fi) 2012-08-28 2012-08-28 Anisomelihapon farmaseuttiset koostumukset ja niiden käyttö

Publications (2)

Publication Number Publication Date
FI20125888A true FI20125888A (fi) 2014-03-01
FI126047B FI126047B (fi) 2016-06-15

Family

ID=49619952

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20125888A FI126047B (fi) 2012-08-28 2012-08-28 Anisomelihapon farmaseuttiset koostumukset ja niiden käyttö

Country Status (8)

Country Link
US (1) US9345687B2 (fi)
EP (1) EP2895162B1 (fi)
JP (1) JP2015530381A (fi)
CN (1) CN104869991B (fi)
CA (1) CA2922642C (fi)
DK (1) DK2895162T3 (fi)
FI (1) FI126047B (fi)
WO (1) WO2014033366A1 (fi)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9623002B2 (en) * 2012-08-28 2017-04-18 John E. Eriksson Pharmaceutical compositions of Anisomelic acid and the use thereof
EP3179998B1 (en) 2014-08-17 2021-05-05 Åbo Akademi Compounds for the treatment of hpv-induced carcinoma
FI20195527A1 (fi) 2019-06-17 2020-12-18 Aabo Akademi Ovatodiolidin farmaseuttiset koostumukset ja niiden käytöt
JP2023526664A (ja) * 2020-05-19 2023-06-22 アージル・バイオテック・ホールディング・カンパニー・リミテッド 線維性疾患の処置または予防におけるテルペノイドの使用
WO2022020676A2 (en) * 2020-07-23 2022-01-27 Arjil Biotech Holding Company Limited Method and composition for inhibiting virus infection
CN112964704B (zh) * 2021-02-04 2024-03-22 甘肃润达药业有限公司 一种防风草内酯检测试纸、比色卡及快速检测方法
CN117500794A (zh) * 2021-06-10 2024-02-02 北京大学深圳研究生院 一种不对称合成(-)-鱼针草酸的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY120392A (en) * 2000-06-08 2005-10-31 Hovid Berhad A novel drug delivery system : formulation for fat-soluble drugs
US20090291976A1 (en) 2006-06-27 2009-11-26 Peter Andrew Ferchmin Neuronal circuit-dependent neuroprotection by interaction between nicotinic receptors
TWI465244B (zh) 2010-12-24 2014-12-21 Ind Tech Res Inst 魚針草萃取物、魚針草內酯及防風草酸在製備預防或治療痛風之醫藥的用途

Also Published As

Publication number Publication date
CA2922642A1 (en) 2014-03-06
JP2015530381A (ja) 2015-10-15
CA2922642C (en) 2021-02-23
FI126047B (fi) 2016-06-15
CN104869991A (zh) 2015-08-26
EP2895162B1 (en) 2018-01-03
WO2014033366A1 (en) 2014-03-06
US9345687B2 (en) 2016-05-24
EP2895162A1 (en) 2015-07-22
US20150202180A1 (en) 2015-07-23
DK2895162T3 (en) 2018-03-26
CN104869991B (zh) 2017-12-08

Similar Documents

Publication Publication Date Title
CO6852076A2 (es) Composiciones farmacéuticas inhalables
IL233756A (en) History of hydroxamic acid and their pharmaceutical preparations
DK3181128T3 (da) Farmaceutisk nilotinib-sammensætning
CO6880066A2 (es) Composición farmacéutica de sabor enmascarado
DK3156056T3 (da) Farmaceutiske sammensætninger der består af sorbitanestere
PT2854768T (pt) Composições farmacêuticas de pemetrexed
DK2922526T3 (da) Fremstilling af semiplastiske farmaceutiske doseringsenheder
FI20135146L (fi) Farmaseuttiset koostumukset ja hoitomenetelmät
BR112014006291A2 (pt) composição e utilização da composição
BR112013014644A2 (pt) composição farmacêutica e complexo
DK2654736T3 (da) Hidtil ukendt farmaceutisk sammensætning
FI20125888A (fi) Anisomelihapon farmaseuttiset koostumukset ja niiden käyttö
DK2897594T3 (da) Farmaceutisk sammensætning
DK2815752T3 (da) Oral farmaceutisk sammensætning
DK2925338T3 (da) Frysetørret formulering af tat-nr2b9c
HK1203149A1 (en) Novel dosage form and formulation of abediterol
SMT201500005B (it) Composizione framaceutica inalabile
CO7000772A2 (es) Composiciones farmacéuticas tópicas que comprenden bexaroteno y corticosteroides
BR112015002646A2 (pt) composto e composição farmacêutica
DK3473255T3 (da) Farmaceutisk formulering omfattende ciclesonid
CU24157B1 (es) Composición farmacéutica de liberación prolongada de trimetazidina
SMT201600419B (it) Composizione farmaceutica contenente fosfolipidi
BR112014017217A2 (pt) agente e composição farmacêutica
CO6990712A2 (es) Combinación farmacéutica antineuritica y composiciones
DK2908836T3 (da) Farmaceutisk formulering indeholdende curcuma

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 126047

Country of ref document: FI

Kind code of ref document: B

PC Transfer of assignment of patent

Owner name: A BO AKADEMI

PC Transfer of assignment of patent

Owner name: ANISON THERAPEUTICS OY